Nile Pharmaceuticals

مادة اعلانية

Latest Update: 17 Sep 2024 15:13 Abu Dhabi Time.

Market Status: Closed

NIPH

Nile Pharmaceuticals

71.50

EGP

-0.170

-0.24%

Open

71.67

Prev Close

71.67

PX_VOLUME

1,446

MARKET CAP (M)

725.66

DAY RANGE

71.11 - 73.00

52 WEEKS

40.25 - 103.99

Stock Statistics

Yearly Change

62.33%

Listed Shares (Million)

10.12

Earnings Multiple

4.12

Average 30-day trading volume

4,166.46

Price-to-book ratio

1.41

Earnings Per Share

11.77

Previous Dividend Distribution

4.75

Dividend Yield

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Dec 31, 2022
Total Revenue		296.69	387.93	378.73	268.93
Gross Profit		66.54	99.51	109.37	75.63
Operating Income		42.77	64.98	81.19	43.74
Profit Margin		8.89	10.87	14.22	9.51

	Period Ending:	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Total Revenue		1,005.22	876.78	755.51	812.54
Gross Profit		271.81	222.34	201.08	253.85
Operating Income		162.76	125.44	95.60	116.39
Profit Margin		11.86	10.23	8.53	11.49

Balance Sheet

	Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Dec 31, 2022
Total Assets		1,420.28	1,201.86	1,106.13	1,038.29	912.49
Total Liabilities		905.13	710.54	573.80	559.81	475.34
Total Equity		515.14	491.33	532.32	478.48	437.15

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.